20,20 0-H), 3.70 (s, 3H, OCH3), 3.77–3.96 (m, 3H, 30, 50, 50 0-H),
4.13–4.15 (m, 1H, 30-H), 4.72, 4.73, 4.75, 4.76 (4s, 1H, a-H),
6.01, 6.03, 6.05 (3s, 1H, 10-H), 6.77, 6.79 (2s, 2H, ArH), 7.31,
7.33 (2s, 2H, ArH), 7.40, 7.41, 7.42, 7.43 (4s, 1H, 6-H).
13C NMR (D2O) dC 11.55, 11.59 (5-CH3), 36.27, 36.36
(C-20), 55.26 (OCH3), 60.36, 60.45 (C-30), 64.02, 64.08,
64.26, 64.32 (C-50), 69.87, 70.44, 71.44, 72.01 (a-C–OH),
83.22, 83.29 (C-40), 84.90, 85.07 (C-10), 110.37, 111.45 (C-5),
128.49, 128.55, 128.71, 128.77 (2 ꢂ C-Ar), 131.28, 131.30,
131.34, 131.36 (2 ꢂ C-Ar), 137.18, 137.29 (C-6), 151.48, 151.55
for the parent aryl nucleoside a-hydroxyphosphonate 1c.
Obtained 0.13 g (yield 75%). 31P NMR (CDCl3) dP 15.07,
15.11, 15.44, 15.46. H NMR (CDCl3) dH 1.84, 1.86 (2s, 3H,
1
5-CH3), 2.01, 2.06, 2.15, 2.17 (4s, 3H, CH3COO), 1.94–2.37
(m, 2H, 20,20 0-H), 3.78, 3.79, 3.80 (3s, 3H, OCH3), 3.89–4.32
(4m, 4H, 40, 30, 50, 50 0-H), 6.06–6.21 (m, 1H, a-H), 6.27–6.35
(m, 1H, 10-H), 6.87–7.49 (m, 10H, 6-H and ArH). 13C NMR
(CDCl3) dC 12.34, 12.42 (5-CH3), 20.62, 20.67, 20.78
(CH3COO), 36.98, 37.06, 37.12, 37.19 (C-20), 55.32 (OCH3),
60.02, 60.08 (C-30), 65.77, 65.84, 65.92, 65.99, 66.32, 66.42,
66.60, 66.69 (C-50), 68.56, 68.67, 68.72, 68.89, 70.88, 71.01,
71.20 (a-C–OH), 81.91, 81.99, 82.06 (C-40), 84.51, 84.57, 84.76,
84.84 (C-10), 111.44, 111.46, 111.53, 111.56 (C-5), 120.02,
120.09, 120.14, 120.18, 120.24 (C-Ar), 129.45–130.08 (5 ꢂ
C-Ar), 134.94, 135.06, 135.17 (C-6), 149.77–150.26 (C-Ar,
C-2), 160.37–160.54 (C-4), 168.94–169.21 (CH3COO). HRMS
[M]ꢁ m/z 586.1711 calculated for C26H29N5O9P 586.1703.
(C-2), 158.28, 158.31, 158.34 (2 ꢂ C-Ar), 166.38, 166.39
+ ꢁ
m/z: 466.1144 calculated for
(C-4). HRMS [M–NH4
C18H21N5O8P 466.1128.
]
30-Azido-30-deoxythymidin-50-yl a-hydroxy(4-chlorophenyl)-
methylphosphonate triethylammonium salt (7d). 0.25 g (yield
1
88%). 31P NMR (CDCl3) dP 16.10, 16.30. H NMR (CDCl3)
dH 1.16, 1.18, 1.21 (t, J = 7.2 Hz, 9H, CH2CH3), 1.92, 1.93,
1.94 (3s, 3H, 5-CH3), 2.30 (s, 3H, CH3), 2.26–2.38 (m, 2H,
20,20 0-H), 2.88, 2.90, 2.93, 2.95 (q, J = 7.2 Hz, 6H, CH2CH3),
3.94–4.30 (3m, 3H, 30, 50, 50 0-H), 4.37–4.41 (m, 1H, 40-H), 4.85,
4.88, 4.90, 4.92 (4s, 1H, a-H), 6.12, 6.15, 6.17, 6.19 (4s, 1H,
10-H), 7.27, 7.28 (2s, 2H, ArH), 7.47–7.52 (m, 2H, ArH), 7.66,
7.69 (2s, 1H, 6-H). 13C NMR (CDCl3) dC 8.41 (CH2CH3),
12.42 (5-CH3), 37.77, 37.86 (C-20), 45.51 (CH2CH3), 61.55
(C-30), 64.87, 65.11, 65.19 (C-50), 69.59, 70.13, 71.86, 72.05
(a-C–OH), 83.89 (C-40), 85.22, 85.36 (C-10), 110.96, 111.05
(C-5), 127.80 (C-Ar), 128.02, 128.08 (C-Ar), 128.22, 128.28
(C-Ar), 132.36 (C-Ar), 135.71, 135.80 (C-Ar), 139.02, 139.32 (C-6),
150.64 (C-2), 164.44, 164.61 (C-4). HRMS [M–Et3NH+]ꢁ m/z:
470.0646 calculated for C17H18N5O7P 470.0632.
30-Azido-30-deoxythymidin-50-yl a-acetyloxy(4-methoxyphenyl)-
methylphosphonate triethylammonium salt (10). 0.14 g of 7c
dissolved in 3 mL of methylene chloride containing pyri-
dine (10% v/v) was treated with acetic anhydride (0.28 mL,
10 molar equiv.) at room temperature. After the reaction was
complete (0.5 h, 31P NMR), the solvent was evaporated and
compound 10, after dissolving in a small volume of methylene
chloride, precipitated from n-hexane. 0.16 g (yield 88%) of
white solid. 31P NMR (CDCl3) dP 13.08, 13.13. 1H NMR
(CDCl3) dH 1.13, 1.16, 1.18 (t, J = 7.2 Hz, 9H, CH2CH3),
1.90, 1.94, 2.03 (3s, 3H, CH3COO), 2.09, 2.10 (2s, 3H, 5-CH3),
2.23–2.31 (m, 2H, 20,200-H), 2.82, 2.85, 2.87, 2.91 (q, J = 7.2 Hz,
6H, CH2CH3), 3.76 (s, 3H, OCH3), 3.96–4.30 (3m, 4H, 40, 30,
50, 50 0-H), 6.02, 6.05, 6.06, 6.09 (4s, 1H, a-H), 6.20-6.24
(m, 1H, 10-H), 6.81, 6.84 (2s, 2H, ArH), 7.41, 7.44 (2s, 2H,
ArH), 7.56, 7.59 (2s, 1H, 6-H). 13C NMR (CDCl3) dC 8.08,
8.34 (CH2CH3), 12.30, 12.36 (5-CH3), 20.98, 21.03, 21.05
(CH3COO), 37.24 (C-20), 45.39 (CH2CH3), 55.25, 55.28
(OCH3), 60.59, 60.66 (C-30), 64.77, 64.83, 65.10, 65.16
(C-50), 70.45, 70.61, 72.08, 72.24 (a-C–OH), 83.02, 83.09
(C-40), 84.53 (C-10), 111.18, 111.21 (C-5), 113.59 (2 ꢂ C-Ar),
126.07 (C-Ar), 127.54, 127.61 (C-Ar), 128.29 (C-Ar), 129.25,
129.29 (C-6), 150.31 (C-2), 159.47, 159.48 (C-Ar), 163.89
(C-4), 169.68, 169.76 (CH3COO). HRMS [M–Et3NH+]ꢁ m/z
508.1229 calculated for C20H23N5O9P 508.1234.
30-Azido-30-deoxythymidin-50-yl a-hydroxy(4-nitrophenyl)-
methylphosphonate triethylammonium salt (7e). 0.25 g (yield
1
85%). 31P NMR (CDCl3) dP 15.09, 15.31. H NMR (CDCl3)
d
H 1.15, 1.17, 1.20 (t, J = 7.2 Hz, 9H, CH2CH3), 1.93 (3s, 3H,
5-CH3), 2.28–2.41 (m, 2H, 20,200-H), 2.90, 2.93, 2.95, 2.98
(q, J = 7.2 Hz, 6H, CH2CH3), 3.91–4.30 (3m, 3H, 30, 50,
50 0-H), 4.37–4.40 (m, 1H, 40-H), 5.00, 5.03, 5.06, 5.08 (4s, 1H,
a-H), 6.08, 6.10, 6.13, 6.15 (4s, 1H, 10-H), 7.62, 7.63, 7.65, 7.66
(2d, J = 0.9, 1.2 Hz, 1H, 6-H), 7.73–7.78 (m, 2H, ArH),
8.15–8.18 (m, 2H, ArH). 13C NMR (CDCl3) dC 8.37
(CH2CH3), 12.40 (5-CH3), 37.78, 37.87 (C-20), 45.43
(CH2CH3), 61.39 (C-30), 64.92, 65.00, 65.05, 65.27, 65.30
(C-50), 70.33, 70.41, 72.21, 72.29 (a-C–OH), 83.72, 83.75,
83.81, 83.83 (C-40), 85.32, 85.44 (C-10), 110.96, 111.03
(C-5), 120.08, 120.16 (C-Ar), 127.25, 127.30, 127.43, 127.49
(2 ꢂ C-Ar), 135.65, 135.75 (C-6), 146.72, 146.76 (C-Ar),
148.38, 148.40 (C-Ar), 148.71 (C-Ar), 150.65, 150.67 (C-2),
164.58, 164.73 (C-4). HRMS [M–Et3NH+]ꢁ m/z 481.0888
calculated for C17H18N6O9P 481.0873.
Acknowledgements
Financial support from the government of the Polish Republic
(partial project no. PBZ-MNiSW-07/I/2007; 2008–2010) is
gratefully acknowledged.
References
30-Azido-30-deoxythymidin-50-yl phenyl a-acetyloxy(4-methoxy-
phenyl)methylphosphonate (9). 0.16 g of 1c dissolved in 3 mL of
methylene chloride containing pyridine (10% v/v) was treated
with acetic anhydride (0.28 mL, 10 molar equiv.) at room
temperature. After the reaction was complete (2.5 h, 31P
NMR), the resulting mixture was washed with water, the
organic layer separated after drying over anhydrous Na2SO4
and evaporated. The further isolation procedure for 9 was as
1 For the most recent review, see: S. J. Hecker and M. D. Erion,
J. Med. Chem., 2008, 51, 2328–2345.
2 A. Szymanska, M. Szymczak, J. Boryski, J. Stawinski,
´
A. Kraszewski, G. Collu, G. Sanna, G. Giliberti, R. Loddo and
P. La Colla, Bioorg. Med. Chem., 2006, 14, 1924–1934.
3 RPMI multicomponent aqueous solution: Sigma cat. no. R8758;
foetal bovine serum (FBS): Sigma cat. no. F6178.
4 C. Meier, L. W. Habel, J. Balzarini and E. De Clercq, Liebigs Ann.
Chem., 1995, 2195–2202.
ꢀc
This journal is The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2010
982 | New J. Chem., 2010, 34, 976–983